A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV.

Saved in:
Bibliographic Details
Title: A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV.
Authors: Bergmann, L.1 l.bergmann@em.uni-frankfurt.de, Maute, L.1, Heil, G.2, Rüssel, J.3, Weidmann, E.4, Köberle, D.5, Fuxius, S.6, Weigang-Köhler, K.7, Aulitzky, W.E.8, Wörmann, B.9, Hartung, G.10, Moritz, B.11, Edler, L.12, Burkholder, I.13, Scheulen, M.E.14, Richly, H.14
Source: European Journal of Cancer. Jan2015, Vol. 51 Issue 1, p27-36. 10p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2014.10.010